CGRWX
Price
$33.82
Change
-$0.08 (-0.24%)
Updated
Sep 8 closing price
Net Assets
772.15M
VVIAX
Price
$71.07
Change
-$0.12 (-0.17%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

CGRWX vs VVIAX

Header iconCGRWX vs VVIAX Comparison
Open Charts CGRWX vs VVIAXBanner chart's image
Invesco Comstock Select A
Price$33.82
Change-$0.08 (-0.24%)
VolumeN/A
Net Assets772.15M
Vanguard Value Index Adm
Price$71.07
Change-$0.12 (-0.17%)
VolumeN/A
Net Assets202.84B
CGRWX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGRWX vs. VVIAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRWX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. CGRWX (772M). VVIAX pays higher dividends than CGRWX: VVIAX (2.10) vs CGRWX (1.46). CGRWX was incepted earlier than VVIAX: CGRWX (40 years) vs VVIAX (25 years). CGRWX (0.93) is less costly to investors than VVIAX (0.05). CGRWX is a more actively managed with annual turnover of: 70.00 vs. VVIAX (9.00). CGRWX has a lower initial minimum investment than VVIAX: CGRWX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 8.94 vs. CGRWX (-1.18). VVIAX return over 5 years is better than : 70.93 vs. CGRWX (54.74).
CGRWXVVIAXCGRWX / VVIAX
Total Expense Ratio0.920.051,840%
Annual Report Gross Expense Ratio0.930.051,860%
Fund Existence40 years25 years-
Gain YTD9.4537.668123%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets772M203B0%
Annual Yield % from dividends1.462.1069%
Returns for 1 year-1.188.94-13%
Returns for 3 years4.8331.7915%
Returns for 5 years54.7470.9377%
Returns for 10 years27.79132.8021%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOS0.810.02
+2.42%
Atossa Therapeutics
IBO0.610.01
+1.16%
Impact BioMedical Inc.
BCAL17.200.10
+0.58%
California BanCorp
FFBC26.34-0.04
-0.15%
First Financial Bancorp
MAS75.80-0.27
-0.35%
Masco Corp